Pain
Conditions
Brief summary
The purpose of this study is to investigate the effectiveness of a systematic approach to pain assessment in the critically ill patients' outcome The investigators hypothesize that, patients who will undergo systematic pain assessment and they will have their results notified to physicians and nurses, will demonstrate favorable effects on pain intensity, more efficient use of sedatives and analgesics, duration of mechanical ventilation, length of ICU stay, mortality, adverse events and complications, in relation to patients who will receive standard care alone. Moreover it is expected that they will demonstrate altered levels of plasma neuropeptides and biochemical markers in peripheral blood.
Detailed description
Appropriate pain management depends on the systematic and comprehensive assessment of pain. Inaccurate pain assessment and the resulting inadequate treatment of pain in critically ill adults can have significant physiological and psychological consequences. The investigators will examine whether a systematic pain assessment approach can improve patients outcomes. 120 ICU patients will be randomized either to control or intervention group. The control group will receive standard care plus pain assessments but nurses and physicians will be blind of these results. The intervention group will receive standard care plus systematic pain assessment and the results will be notified to nurses and physicians.
Interventions
OTHERSystematic pain assessment
Systematic assessment of pain twice daily with the use of 2 different behavioral pain tools (Behavioral Pain Scale - BPS, and Critical Care Pain Observation Tool - C-POT) for non-communicative patients and Numerical Rating Scale (NRS) 1-10 for communicative patients.
OTHERNotification of results of assessments
Pain assessments will be carried out by independent investigators who will notify the results to ICU nurses and physicians and observe and document their reaction
Sponsors
Nicosia General Hospital
Cyprus University of Technology
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* 18 years and older * All patients with an estimated source of pain or due to immunological process as trauma, surgery, or due to general factors such as endotracheal intubation, interventional catheters
Exclusion criteria
* Length of stay in the ICU \<24 hours * The patient receives neuromuscular blockers, * The patient has a disease or condition, such as Guillain-Barre, peripheral neuropathy, which modifies sensory transmission of painful stimuli * The patient has a disease or condition which complicates the assessment of pain behavior, such as decerebration or vegetative state, agitation\> 3 in the Richmond Agitation sedation Scale (RASS)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| a) Level of pain (intensity, incidence of high levels of pain with a numerical pain scale NRS> 6, Behavioral pain scale (BPS) > 5 and Critical pain observation Tool (C-POT) >2 | morning between 9:00-11: hrs, and afternoon between 4:00-6:00 hrs) for ten continuous days |
| To investigate the effect of the systematic assessment of pain among patients groups - control and intervention as to:The total dose, frequency of administration and the type of analgesics and sedatives received | every 24 hrs for ten continuous days |
Secondary
| Measure | Time frame |
|---|---|
| Effect of the systematic evaluation of pain among patients groups - control and intervention as to:The levels of biochemical marker corticotrophin hormone -ACTH in the serum | morning 1st day intervention (one sample), 3rd day intervention (second sample), 5th day intervention (third sample) |
| Effect of the systematic evaluation of pain among patients groups - control and intervention as to: The levels of biochemical marker, b-endorphin in the serum | morning 1st day intervention (one sample), 3rd day intervention (second sample), 5th day intervention (third sample) |
| Effect of the systematic evaluation of pain among patients groups - control and intervention as to: The levels of neuropeptide Y | morning 1st day intervention (one sample), 3rd day intervention (second sample), 5th day intervention (third sample) |
| Effect of the systematic evaluation of pain among patients groups - control and intervention as to:The degree of sedation/agitation | morning between 9:00-11: hrs, and afternoon between 4:00-6:00 hrs) for ten continuous days |
| To investigate the effect of the systematic assessment of pain among patients groups - control and intervention as to duration of mechanical ventilation | Day and time of initiation of mechanical ventilation till the day and time of end of mechanical ventilation, up to six months. |
| To investigate the effect of the systematic assessment of pain among patients groups - control and intervention as to length of stay in the ICU | From the day of admission to ICU till the day of discharge from ICU, up to six months |
| To investigate the effect of the systematic assessment of pain among patients groups - control and intervention as to the occurrence of adverse events | every 24 hrs for ten continuous days |
| Effect of the systematic evaluation of pain among patients groups - control and intervention as to: The levels of neuropeptide , substance P in the serum | morning 1st day intervention (one sample), 3rd day intervention (second sample), 5th day intervention (third sample) |
| Effect of the systematic evaluation of pain among patients groups - control and intervention as to:The levels of biochemical marker, cortisol, in the serum | morning 1st day intervention (one sample), 3rd day intervention (second sample), 5th day intervention (third sample) |
Countries
Cyprus
Contacts
Primary ContactEvanthia G Georgiou, PhD Cand
Backup ContactElizabeth DE Papathanassoglou, PhD
Outcome results
None listed